BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Abid S, Ali S, Baig MA, Waheed AA. Is it time to replace propranolol with carvedilol for portal hypertension? World J Gastrointest Endosc 2015; 7(5): 532-539 [PMID: 25992192 DOI: 10.4253/wjge.v7.i5.532]
URL: https://www.wjgnet.com/1948-5182/full/v7/i5/532.htm
Number Citing Articles
1
Samira Ben Brahim, Daniel Hartmann, Michael W. Müller, Helmut Friess. Viszerale Operationen bei Patienten mit Leberzirrhose - was ist zu beachten?Gastro-News 2020; 7(5): 45 doi: 10.1007/s15036-020-1371-0
2
Qi Zhang, Xin Wang, Hongjiao Xue, Baolin Huang, Zimin Lin, Zheng Cai. Determination and Comparison of the Solubility, Oil–Water Partition Coefficient, Intestinal Absorption, and Biliary Excretion of Carvedilol EnantiomersAAPS PharmSciTech 2021; 22(1) doi: 10.1208/s12249-020-01906-7
3
Jin-Feng Yang, Neng Cheng, Sheng Ren, Xiang-Ming Liu, Xian-Tao Li. Characterization and molecular basis for the block of Kv1.3 channels induced by carvedilol in HEK293 cellsEuropean Journal of Pharmacology 2018; 834: 206 doi: 10.1016/j.ejphar.2018.07.025
4
Mohamed Balaha, Samah Kandeel, Waleed Barakat. Carvedilol suppresses circulating and hepatic IL-6 responsible for hepatocarcinogenesis of chronically damaged liver in ratsToxicology and Applied Pharmacology 2016; 311: 1 doi: 10.1016/j.taap.2016.10.012
5
Takashi Tajiri, Hiroshi Yoshida, Hiroshi Makino, Atsushi Hirakata, Junji Ueda, Hideyuki Takata, Yasuhiro Mamada, Nobuhiko Taniai, Eiji Uchida. Clinical Investigation of Portal Hypertension2019; : 593 doi: 10.1007/978-981-10-7425-7_61
6
Eula Plana Tetangco, Rogelio G. Silva, Edgar V. Lerma. Portal hypertension: Etiology, evaluation, and managementDisease-a-Month 2016; 62(12): 411 doi: 10.1016/j.disamonth.2016.08.001
7
Karn Wijarnpreecha, Fang Li, Yang Xiang, Xun Xu, Cong Zhu, Vahed Maroufy, Qing Wang, Wei Tao, Yifang Dang, Huy Anh Pham, Yujia Zhou, Jianfu Li, Xinyuan Zhang, Hua Xu, C. Burcin Taner, Liu Yang, Cui Tao. Nonselective beta‐blockers are associated with a lower risk of hepatocellular carcinoma among cirrhotic patients in the United StatesAlimentary Pharmacology & Therapeutics 2021; 54(4): 481 doi: 10.1111/apt.16490
8
Chantelli Iamblaudiot Razafindrazoto, Lova Dany Ella Razafindrabekoto, Domoina Harivonjy Hasina Laingonirina, Raveloson Raveloson, Anjaramalala Sitraka Rasolonjatovo, Andry Lalaina Rinà Rakotozafindrabe, Tovo Harimanana Rabenjanahary, Soloniaina Hélio Razafimahefa, Rado Manitrala Ramanampamonjy. Carvedilol versus propranolol in the prevention of variceal rebleeding in hepatosplenic schistosomiasis: Efficacy and safety JGH Open 2022; 6(3): 213 doi: 10.1002/jgh3.12721